D
David T. Mauger
Researcher at Pennsylvania State University
Publications - 240
Citations - 18009
David T. Mauger is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Asthma & Medicine. The author has an hindex of 68, co-authored 207 publications receiving 15064 citations. Previous affiliations of David T. Mauger include Lake County & Penn State Milton S. Hershey Medical Center.
Papers
More filters
Journal ArticleDOI
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
Adrian R. Martineau,David A. Jolliffe,Richard Hooper,Lauren Greenberg,John F. Aloia,Peter Bergman,Gal Dubnov-Raz,Susanna Esposito,Davaasambuu Ganmaa,Adit A. Ginde,Emma C Goodall,Cameron C. Grant,Chris Griffiths,Wim Janssens,Ilkka Laaksi,Semira Manaseki-Holland,David T. Mauger,David R. Murdoch,Rachel E. Neale,Judy R. Rees,Steve Simpson,Iwona Stelmach,Geeta Trilok Kumar,Mitsuyoshi Urashima,Carlos A. Camargo +24 more
TL;DR: Vitamin D supplementation was safe and it protected against acute respiratory tract infection overall and patients who were very vitamin D deficient and those not receiving bolus doses experienced the most benefit.
Journal ArticleDOI
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
Theresa W. Guilbert,Wayne J. Morgan,Robert S. Zeiger,Robert S. Zeiger,David T. Mauger,Susan J. Boehmer,Stanley J. Szefler,Leonard B. Bacharier,R.F. Lemanske,Robert C. Strunk,David B. Allen,Gordon R. Bloomberg,Gregory P. Heldt,Marzena E. Krawiec,Gary L. Larsen,A.H. Liu,Vernon M. Chinchilli,Christine A. Sorkness,Lynn M. Taussig,Fernando D. Martinez +19 more
TL;DR: In preschool children at high risk for asthma, two years of inhaled-corticosteroid therapy did not change the development of asthma symptoms or lung function during a third, treatment-free year, and these findings do not provide support for a subsequent disease-modifying effect of inhaling corticosteroids after the treatment is discontinued.
Journal ArticleDOI
Classifying Asthma severity in children: Mismatch between symptoms, medication use, and lung function
Leonard B. Bacharier,Robert C. Strunk,David T. Mauger,Deborah K. White,Robert F. Lemanske,Christine A. Sorkness +5 more
TL;DR: In children, asthma severity classified by symptom frequency and medication usage does not correlate with FEV(1) categories defined by National Asthma Education and Prevention Program Guidelines, whereas FEV (1)/FVC declines as asthma severity increases.
Journal ArticleDOI
Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
Robert F. Lemanske,David T. Mauger,Christine A. Sorkness,Daniel J. Jackson,Susan J. Boehmer,Fernando D. Martinez,Robert C. Strunk,Stanley J. Szefler,Robert S. Zeiger,Robert S. Zeiger,Leonard B. Bacharier,Ronina A. Covar,Theresa W. Guilbert,Gary L. Larsen,Wayne J. Morgan,Mark H. Moss,Joseph D. Spahn,Lynn M. Taussig +17 more
TL;DR: LABA step-up was significantly more likely to provide the best response than either ICS or LTRA step- up, however, many children had a best response to ICSor LTRAstep-up therapy, highlighting the need to regularly monitor and appropriately adjust each child's asthma therapy.
Journal ArticleDOI
COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
Michael C. Peters,Satria Sajuthi,Peter Deford,Stephanie A. Christenson,Cydney Rios,M.T. Montgomery,Prescott G. Woodruff,David T. Mauger,Serpil C. Erzurum,Mats W. Johansson,Loren C. Denlinger,Nizar N. Jarjour,Mario Castro,Annette T. Hastie,Wendy C. Moore,Victor E. Ortega,Eugene R. Bleecker,Sally E. Wenzel,Elliot Israel,Bruce D. Levy,Max A. Seibold,John V. Fahy +21 more
TL;DR: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.